# Eli Lilly to allow more patients to apply for special access to unapproved obesity drug

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-04 14:29 UTC · Category: Business · Sources: 9 · Current Velocity: 8.25

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Houston Chronicle | Eli Lilly will offer experimental obesity drug early to some patients. Who qualifies? | 2026-08-03 20:50 | [Source Link](https://news.google.com/rss/articles/CBMipgFBVV95cUxQZEhwZHREZENuTDVBV2NucGJldkF1akVPWlNDN0I1ZzhUZEFnSm1rRkFkQTRfenhRbng3bWgxaEgzdzU1Tm5WQ3pMZS1aS2pTVDhJZ0xNQzhkUUpOb25oTTJRTGZXMWw5aHFoVkhuMUs0SVFjQWpITnVmSi1VOV80QlAtdnRXVEJjNTFWSUd5cHlXTVRQWXh5V1RGeWN2V09EZlNQalNB?oc=5) |
| MDLinx | Retatrutide access expands, putting physicians on the front line of ‘next-gen’ GLP-1 demand | 2026-08-03 20:50 | [Source Link](https://news.google.com/rss/articles/CBMi2gFBVV95cUxPaVEydjM4OGxWSmMzQUQtRGJ4U05GYmpKeGlDejVuazVicWxLb1NiYkk1TEFOTFFxZjFzcGt2dzhmZ1FXWmRuTl9Kbk81YjRxWmZSb1N5TDVOYTEwUW1ESGlOYWRYTzBhdEkzX2N4dnFLZHBDZEJOaFh1SHZ0dGotcGQ1cURYMGk5T1NlYl9Lc19Ba3hsdl9TWDUtRDFrTmRtVDBMWFQyUGdMOUFNQ0Zzem45MVg1T2hJX2tFSFNqTjF2Sms5dWtEQ2NWcVdONXFwaC1LMGFlSFNUZw?oc=5) |
| STAT | Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and more | 2026-08-03 20:50 | [Source Link](https://news.google.com/rss/articles/CBMirAFBVV95cUxPUjdfcmtFb3pFalBZVVY1ZnlkSkE2RklYMXBPVVdrSy04ZDUzM09tSFo3NXB5VHhFQlEySENBemhLcmI1UWt2V0R1SllValNpY056TXFVQkdxeTVBNWtNSHFNRFpYYlItUVpZQmtPSTZSQ25qdEhTVDBnNVlYVkloT25mSk5fZ09FTnZQVHpqRTBNcHI2WDRTSWhkWVlaRzdtd1VjdnN4YWhvUnhC?oc=5) |
| RAPS | Recon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca | 2026-08-03 20:50 | [Source Link](https://news.google.com/rss/articles/CBMi8AFBVV95cUxOSVExR0pEVTJ6OWR3eHd0WnB3ZlZTa052NHV6aHktLU5taXh5dU4wSFlfcFhHOG9Ncl9VMjExRFlzRTJxTW5jZVJUZ2M2akEyMDJIcWdCLXUxZmt1RklLcFg4OEUzMl9SdzJSMWh2OUhKMEVWWjdxdGJMRVZQQXNscUhpUmxTTVI2Y052eHUtcVdlV2VSZ25vazUwV29Cbm55VkhDYkxDdHptOGdYb0MyS0YyVE93NmJtMXgwSlRJNjBkYm5ycDNxVFQ4dWRqYXJNZmN1dTVpNlQyQ0VmU3ZPUnlmdFpBdmVqM3h4WjkwaDU?oc=5) |
| qz.com | Eli Lilly is allowing more patients early access to its experimental weight loss drug | 2026-08-03 20:50 | [Source Link](https://news.google.com/rss/articles/CBMid0FVX3lxTE1GVzBoMzVDc2Q0bjM4Um96aW5PQk1QTmhnQXNJbmw3SkNwWUVjcnJhcTdUV1ltejBEQTJETkg0TDU4NGZ3aWdfMlJfOHJZRWFFSkVCa05CZ3d5SXlyeWh5dDY2MnpBTlpnb2ZGVWthV3ZQQWFvcGtJ?oc=5) |
| STAT | Three biotechs with three news updates | 2026-08-03 20:50 | [Source Link](https://news.google.com/rss/articles/CBMirAFBVV95cUxNVndmeVFhbVpWTzczRWx4WGF3S2YzeVdSTWcwa2lUVXdkeFFQSFlzS21tRTZEQVR1R3c2MnBucmdJYXFhV0phcU1HaWo1RjFrcXRlcmhjLXByWFlCV2xxQnRRLTUyZXBGQmFqSWhvNm9HUnNMeVN4aVNrNWdEWlNla1BwUUNESVZKa28wOTduNE5jLWplQmxQN1Z6emFOSk9DZG5QZjFGNVNiUHNw?oc=5) |
| Marie Claire | This Next-Gen GLP-1 Is Blowing Up the Black Market Economy | 2026-08-03 20:50 | [Source Link](https://news.google.com/rss/articles/CBMibEFVX3lxTE1hdjhPNWFzYU1FQ1Fwb3h5TzZCNHVrUUE1TFI4bE4yWnJEeVNGdXA5c0RjR183SDBPVjBvRHJwcDI1dk85MnJyeXJySF9RdTJORDctWm5ydV93TGZHQjR4Nzh5SUZzSUpvb3FuSA?oc=5) |
| FC Bayern | Retta Weight Loss: The Evidence, Benefits, and Realistic Expectations | 2026-08-03 20:50 | [Source Link](https://news.google.com/rss/articles/CBMi4AFBVV95cUxQMzJsVEk0QnlFenBiTi1MRVljX2RhaUFoTVNrcG5Yc0NWUFJxeVNHRkZtdmlabjB1NHNLaHZXdmJ5WHhZdkNUTncyMzhTcmN0dE1hNjRQbnZZQXpJMXJMUmx6TGVpeFdvMGthb1VyMl9aNFhjaVRNeFI1Q1pCbmc1SXZRZlktZ0tPb3A5WXlXV3BQeElGamluSlVmMHQyYUtMWjFQOHVzTE0zS2ZjUVgydURTS2h4dmRCUGxmTWlJcHdWMUV0SFZrb0prel9KYlgtVlFMODF1eGljUU5qakFUdQ?oc=5) |
| FirstWord Pharma | Spotlight On: Good news and bad news for Lilly's triple agonist | 2026-08-03 20:50 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE90REhGZHFwR200aThXbWF5ek0yVGhtV2kwSlpMdVBfa1hnSmhxdHJvV3VrVG05ekNhZXFMRGFwd2w1ck12ZjYzU1kzWm9BT1NKWU9F?oc=5) |
| Reuters | Eli Lilly to offer early access to next-gen obesity drug to some patients | 2026-08-03 20:50 | [Source Link](https://news.google.com/rss/articles/CBMiuAFBVV95cUxQSUF6THY1UW04aGlCR241STFzUE94MXlyMjZFSVNWaG9aYkRPVFVvdW5FRVZ3NHd3RXQzSjkybFhCWEhZZVpNTExxSDlwNDNRWW95SG0xcGVUVVozU09SMHR3RUR5b3Q2SFNYaTZvbzBWbV9fNTA4WjVOTGk1cUdhYkN2bl9rR19VcmpFV256VktIb243aHpZQ1RxNVR5ZldFNkpKUk9NNVFjb2Nmd1NxcFBDVzFnMURv?oc=5) |
| STAT | Eli Lilly to allow more patients to apply for special access to unapproved obesity drug | 2026-08-03 20:50 | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxPZlc2WHdHQWtOSElxbmxZa1ZTQ2wxVTFmZ1dlN00teWRicmdqZTJVTjZUSjNKcEltUHZITTViR3U5NFk3cXRmWmRGWGpOSERRWWFta3NqNjlFRF9qRjVmNGNXTEVUazNURjZkRUZFQjl1QkxuNVM4aWlwNGtYVmY0OG5Sc042Q3FrRGVLVTJTaEp1R0dLVnA2My1YUG84MmJCdEdWWEMzNGZpQ2ZPR205WW15b2U?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-04/eli-lilly-to-allow-more-patients-to-apply-for-special-access-to-unapproved*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*